Author | Leonard Calabrese DO


PML and Rituximab: What Rheumatologists Should Know

July 25, 2013

Progressive multifocal leukoencephalopathy (PML) is a rare but potentially fatal adverse effect of biologic therapy for rheumatologic disorders. Here, a specialist on the topic from Cleveland Clinic offers a brief review of the risks and realities.